The political fortunes of a proposal to expand federal aid for embryonic stem cell research have changed since the House passed a bill last year. A scientist's fraud in South Korea raised questions about the research, and a growth in independently funded research is sparking questions about whether NIH funding is necessary.

Related Summaries